ImageneBio (IMA) Current Leases (2020 - 2025)

ImageneBio has disclosed Current Leases across 6 years of filings, most recently posting $2.3 million for Q4 2025.

• Current Leases for Q4 2025 came in at $2.3 million, up 632.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (up 632.04% YoY), and the FY2025 annual result was $2.3 million, up 632.04% from the prior year.
• Current Leases came in at $2.3 million for Q4 2025 at ImageneBio, up from $2.2 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.9 million in Q3 2024 to a low of $309000.0 in Q4 2024.
• The 5-year median for Current Leases is $1.9 million (2023), against an average of $2.5 million.
• Across the five-year window, Current Leases jumped 895.16% in 2021 and tumbled 91.32% in 2024, its largest moves.
• ImageneBio's Current Leases stood at $1.9 million in 2021, then grew by 3.03% to $1.9 million in 2022, then jumped by 86.58% to $3.6 million in 2023, then sank by 91.32% to $309000.0 in 2024, then soared by 632.04% to $2.3 million in 2025.
• The last three Current Leases figures came in at $2.3 million (Q4 2025), $2.2 million (Q3 2025), and $3.8 million (Q2 2025), per Business Quant data.